Karachi: Ghani Chemical Industries Ltd. (GCIL) held a briefing for analysts to discuss its financial results for fiscal year 2025 and provide an outlook for the future. The company reported a substantial increase in profitability and revenue, driven by operational efficiencies and heightened demand.

GCIL announced that its profitability rose by 2.6 times year-on-year, reaching PkR2.0 billion, equivalent to an earnings per share (EPS) of PkR3.5. In comparison, the previous fiscal year saw a profit of PkR0.8 billion with an EPS of PkR1.4. This increase was attributed to higher sales and improved operational efficiencies.

Revenue for the fiscal year surged by 37% year-on-year, totaling PkR8.7 billion, up from PkR6.4 billion in the same period last year. The company indicated that the rise in revenue was primarily driven by increased demand for healthcare gases.

GCIL operates across several segments, including industrial gases, medical gases, and chemical solutions. The company highlighted its ongoing commitment to meeting the growing needs of the healthcare sector through its product offerings.

The analyst briefing provided an opportunity for GCIL to communicate its financial health and strategic direction, emphasizing the robust performance in the fiscal year and the anticipated growth in its operational sectors.